Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004766661 | SCV005381620 | pathogenic | Fanconi anemia | 2024-08-28 | criteria provided, single submitter | clinical testing | Variant summary: The variant involves the deletion of exons 15-28 in the FANCA gene. A presumed nomenclature of c.(1359+1_1360-1)_(2778+1_2779-1)del has been designated for the purposes of this classification. This Copy Number Variant (CNV) is predicted to result in an in-frame deletion within this gene. The variant was absent in 19932 control chromosomes. c.(1359+1_1360-1)_(2778+1_2779-1)del has been reported in the literature in individuals affected with Fanconi Anemia (e.g. DeRocco_2014, Nicchia_2015, Pilonetto_2017). Additionally, an in-frame deletion within the deleted region (Deletion exons 16-17 Variation ID: 3243252) has been determined to be pathogenic, supporting the critical relevance of this region to FANCA protein function. The following publications have been ascertained in the context of this evaluation (PMID: 24584348, 28717661, 26740942). ClinVar contains an entry for this variant (Variation ID: 974119). Based on the evidence outlined above, the variant was classified as pathogenic. |